PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes

PIK3CA mutations are frequently diagnosed in diverse cancers and may predict response to PI3K/AKT/mTOR inhibitors. It remains unclear whether they are associated with other characteristics. We analyzed characteristics and outcome of 90 consecutive patients with diverse advanced tumors and PIK3CA mut...

Descripción completa

Detalles Bibliográficos
Autores principales: Janku, Filip, Wheler, Jennifer J., Naing, Aung, Stepanek, Vanda M., Falchook, Gerald S., Fu, Siqing, Garrido-Laguna, Ignacio, Tsimberidou, Apostolia M., Piha-Paul, Sarina A., Moulder, Stacy L., Lee, J. Jack, Luthra, Rajyalakshmi, Hong, David S., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681495/
https://www.ncbi.nlm.nih.gov/pubmed/23248156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681495/
https://www.ncbi.nlm.nih.gov/pubmed/23248156

Ejemplares similares